A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
Clinical trial NCT04240223 · COMPLETED
Trial details
- NCT number
- NCT04240223
- Sponsor
- Innovation Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2020-02-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.